In order to increase the rate of CFTR mutation detection and to correctly evaluate the residual risk of being a CF carrier after molecular analysis, it is essential that genetic tests are designed based on the frequency profile characteristic for a given population and that the sensitivity to detect mutations is as high as possible [4]–[6]. The gene discussed is CFTR; the disease is cystic fibrosis.